These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16813733)

  • 1. Statement of the problem.
    Steiner G;
    Am J Cardiol; 2006 Jun; 97(12A):3G-8G. PubMed ID: 16813733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Magee MF; Isley WL;
    Am J Cardiol; 2006 Jun; 97(12A):20G-30G. PubMed ID: 16813735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Brooks MM; Frye RL; Genuth S; Detre KM; Nesto R; Sobel BE; Kelsey SF; Orchard TJ;
    Am J Cardiol; 2006 Jun; 97(12A):9G-19G. PubMed ID: 16813734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial.
    Barsness GW; Gersh BJ; Brooks MM; Frye RL;
    Am J Cardiol; 2006 Jun; 97(12A):31G-40G. PubMed ID: 16813736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation of alternative strategies to treat patients with diabetes mellitus and coronary artery disease.
    Hlatky MA; Melsop KA; Boothroyd DB;
    Am J Cardiol; 2006 Jun; 97(12A):59G-65G. PubMed ID: 16813739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ancillary studies in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial: Synergies and opportunities.
    Sobel BE;
    Am J Cardiol; 2006 Jun; 97(12A):53G-58G. PubMed ID: 16813738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of diabetes mellitus in patients with cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Goldfine AB; Fonseca V
    Circulation; 2010 Jun; 121(22):2447-9. PubMed ID: 20530022
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular clinical trials in patients with diabetes mellitus: lessons from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Study.
    Solomon SD
    Circulation; 2010 Jun; 121(22):2453-5. PubMed ID: 20530024
    [No Abstract]   [Full Text] [Related]  

  • 9. Has anything changed in multivessel coronary artery revascularization in diabetes since BARI?
    Kapur A; Bartolini D; Beatt KJ
    Ital Heart J; 2004 May; 5(5):358-63. PubMed ID: 15185899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General cardiology perspective: decision making regarding revascularization of patients with type 2 diabetes mellitus and cardiovascular disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Fuster V; Farkouh ME
    Circulation; 2010 Jun; 121(22):2450-2. PubMed ID: 20530023
    [No Abstract]   [Full Text] [Related]  

  • 11. [The BARI 2D study].
    Mafrici A; Briguori C
    G Ital Cardiol (Rome); 2010 Oct; 11(10):711-7. PubMed ID: 21246772
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis of four randomized controlled trials on long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with stenting for multivessel coronary artery disease.
    Takagi H; Kawai N; Umemoto T
    Am J Cardiol; 2008 May; 101(9):1259-62. PubMed ID: 18435954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of the BARI 2D and COURAGE trials of coronary artery disease.
    Kuller LH
    Coron Artery Dis; 2010 Nov; 21(7):391-6. PubMed ID: 20634693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.
    Brar SS; Syros G; Dangas G
    Angiology; 2008; 59(2 Suppl):83S-8S. PubMed ID: 18544582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M; Malmberg K; Ohrvik J; Rydén L;
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
    Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
    J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing between percutaneous coronary intervention and coronary artery bypass grafting for patients with multivessel disease: what can we learn from the Arterial Revascularization Therapy Study (ARTS)?
    Berger PB; Sketch MH; Califf RM
    Circulation; 2004 Mar; 109(9):1079-81. PubMed ID: 15007018
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal revascularization strategies for multivessel coronary artery disease.
    Daemen J; Serruys PW
    Curr Opin Cardiol; 2006 Nov; 21(6):595-601. PubMed ID: 17053410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians.
    Rodés-Cabau J; Deblois J; Bertrand OF; Mohammadi S; Courtis J; Larose E; Dagenais F; Déry JP; Mathieu P; Rousseau M; Barbeau G; Baillot R; Gleeton O; Perron J; Nguyen CM; Roy L; Doyle D; De Larochellière R; Bogaty P; Voisine P
    Circulation; 2008 Dec; 118(23):2374-81. PubMed ID: 19029471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.